Want to illuminate the benefits of Alzheimer’s disease and related dementias clinical research? OutreachPro offers free videos, handouts, posters, web banner ads, and social media assets to help research teams raise awareness and participation in dementia studies . Learn more: https://lnkd.in/eQ9UAjhk #NIHAging #OutreachPro #ClinicalTrials #Alzheimers #Recruitment
National Institute on Aging (NIA)’s Post
More Relevant Posts
-
Storytelling can be a powerful way to highlight the value of participating in dementia research. Gain access to videos, like Teriko's story on why she participated in a clinical study, and other tools for Alzheimer’s clinical trial recruitment via OutreachPro: https://lnkd.in/eQ9UAjhk. #NIHAging #OutreachPro #ClinicalTrials #Alzheimers #Recruitment
-
Are you involved with research related to Alzheimer's Disease and Related Dementias? Please join me on this webinar showing how the vast amount of fragmented research can be better aligned and shared for greater impact. https://bit.ly/IFI-SAR313 #Alzheimers #Dementia #BrainResearch
-
-
🌟💜 On this World Alzheimer's Day, let's reflect on the global impact of Alzheimer's disease and related dementias. By sharing knowledge and resources, we empower ourselves to make a difference in the lives of those affected and their caregivers. As professionals, Let's work towards improved research, care, and support for Alzheimer's patients, families, and communities.💙🤝 . . . . . . . #WorldAlzheimersDay #AlzheimersAwareness #SupportingFamilies #DementiaCare #EndAlzheimers #MemoryMatters #DementiaAwareness #DementiaSupport #HealthcareAdvocacy #CaringForCaregivers #ORITechnology #ORITechnologyPvtLtd #LabExpert #HIMS #HIS #HMS #Ethos #Swarnopro
-
At the 18th Annual Congress on Controversies in Neurology (CONy 2024) ADI CEO Paola Barbarino discussed with Video Journal of Dementia (VJDementia) about investment in #dementia and Alzheimer's disease therapeutics. She also expressed concerns that patients are being denied their human right to make informed decisions about their treatment options due to access issues. As populations age, dementia is set to become an even more significant health challenge and is currently the 7th leading cause of death globally. #DementiaTreatments #TimeToActOnDementia #WhatsYourPlan #ADI
In the second extract from the interview I talked about in my post yesterday, I raise concerns about the awareness, accessibility, and affordability of new disease-modifying therapies. High costs may prevent reimbursement for those who could benefit. Even before considering treatment costs, global diagnostic capabilities represent a huge barrier, with many healthcare systems lacking the resources and trained clinicians for accurate and timely diagnosis. I also highlight the scarcity of medical professionals who recognize dementia as a disease, citing the 2019 World Alzheimer’s Report where 62% of respondents did not view dementia as a disease, but a normal part of aging. The lack of understanding extends beyond the general public, affecting medical communities and contributing to the stigma surrounding dementia. This interview took place at the 18th Annual Congress on Controversies in Neurology (CONy 2024) in London, UK and is referring to a broader lecture I gave on the subject. https://lnkd.in/eeqci9CA
Barriers to dementia treatment: awareness, accessibility, and affordability
https://www.youtube.com/
-
As the prevalence and complexity of evaluating and managing #dementia increases, primary care physicians are finding themselves on the frontlines of detecting Alzheimer's disease and other forms of cognitive impairment in their patients. But detecting, diagnosing, and treating these conditions, especially in their earliest stages, isn't easy – let alone providing sound, up-to-date counseling and education about what can be done. What symptoms should physicians look out for? What are the available treatments today? And how can physicians provide comprehensive support to their patients and families during and after a dementia diagnosis? In our upcoming webinar on April 2 at 12pm ET, our founder and Chief Medical Officer Joel Salinas, MD, MBA, MSc, FAAN will be leading a workshop session (followed by a Q&A) designed to assist primary care physicians in tackling these questions. Topics will include: 👉 What to do if a patient asks about new treatments for dementia 👉 What's the bottom line on the new #biomarkers - all foam or golden key to diagnosis 👉 How PCPs can provide better support to families using GUIDE Grab your spot today ➡️ https://lnkd.in/gSZXDSmJ #primarycare #alzheimers #brainhealth
-
-
NEW from #CONy2024 | Barriers to #dementia treatment: awareness, #accessibility, and #affordability 🎥 🧠 Paola Barbarino, MA, CEO of Alzheimer's Disease International, raises concerns about the awareness, accessibility, and affordability of new disease-modifying therapies, namely anti-amyloid medications 🔦 High costs may prevent reimbursement for those who could benefit. Even before considering treatment costs, global #diagnostic capabilities represent a huge barrier, with many #healthcare systems lacking the resources and trained #clinicians for accurate and timely diagnosis 🩺 💵 Ms Barbarino highlights the scarcity of medical professionals who recognize #dementia as a disease, citing the 2019 World Alzheimer’s Report where 62% of respondents did not view dementia as a disease, but a normal part of aging 💡 The lack of understanding extends beyond the general public, affecting #medical communities and contributing to the stigma surrounding #dementia Learn more 👉 https://lnkd.in/esXphr3N #VJDementia
In the second extract from the interview I talked about in my post yesterday, I raise concerns about the awareness, accessibility, and affordability of new disease-modifying therapies. High costs may prevent reimbursement for those who could benefit. Even before considering treatment costs, global diagnostic capabilities represent a huge barrier, with many healthcare systems lacking the resources and trained clinicians for accurate and timely diagnosis. I also highlight the scarcity of medical professionals who recognize dementia as a disease, citing the 2019 World Alzheimer’s Report where 62% of respondents did not view dementia as a disease, but a normal part of aging. The lack of understanding extends beyond the general public, affecting medical communities and contributing to the stigma surrounding dementia. This interview took place at the 18th Annual Congress on Controversies in Neurology (CONy 2024) in London, UK and is referring to a broader lecture I gave on the subject. https://lnkd.in/eeqci9CA
Barriers to dementia treatment: awareness, accessibility, and affordability
https://www.youtube.com/
-
🚨 New Presentations on Alzheimer's Diagnosis with Dr. Malaz Boustani! 🚨 🧠 Challenges and Solutions for Timely Diagnosis of AD Discover the benefits of early Alzheimer's diagnosis and the challenges primary care providers face. Dr. Boustani highlights unmet needs in the current clinical pathway and explores potential solutions on the horizon. 🧩 Patient and Caregiver Barriers to Timely Diagnosis of AD Dr. Boustani discusses factors affecting acceptance of dementia screening, the impact of societal stigma, and the necessary changes to enhance early diagnosis. Learn about the key adjustments needed to prepare healthcare systems for timely detection. 📺 Watch Now: https://lnkd.in/ghqYniNq Stay updated and drive change in early Alzheimer's diagnosis and management. Together, we can make a significant impact! #Alzheimers #EarlyDiagnosis #PrimaryCare #HealthcareProfessionals #DementiaAwareness #HealthcareInnovation
-
-
9th Anniversary Featured Content: “Beyond Memory Loss: Optimizing The Role Of Primary Care In Assessing & Treating Agitation In Alzheimer’s Dementia” Agitation is a common and challenging symptom of Alzheimer’s Dementia (AAD). As the prevalence of AAD continues to increase, primary care providers will play an increasingly important role in managing this condition. This on-demand webinar, essential for any primary care provider managing agitation in patients with AAD, explores the unmet needs within this patient population and features experts in the management of AAD within the primary care setting. View this and other AAD content featured during PsychU's 9th anniversary: go.psychu.org/Jd6q #bipolardisorder #bipolar1 #mentalhealth #PsychU
-
Unveiling the complex world of Alzheimer's disease: informational memory fades, but emotional memories linger. Learn how this unique trait affects patients' experiences. #DigiNerve #MedicalStudents #MedicalStudies #MBBS #MedFacts #MedFactswithDigiNerve #DidYouKnow #Fact #Facts #AlzheimersAwareness #MemoryLoss #CognitiveFunction #Dementia #BrainHealth #EmotionalMemories #PatientsExperience #AlzheimersSupport #MemoryLinger #UnderstandingAlzheimers
-
Tomorrow is World Alzheimer’s Day. Curious about core competencies in delivering primary care to individuals with ADRD? View our webinar here: https://lnkd.in/e35w3AHb #alzheimers #alzheimersawareness #dementia #worldalzheimersmonth #NeverTooEarly #NeverTooLate
